131 related articles for article (PubMed ID: 19439551)
1. Dependence of the localization and function of the human cytomegalovirus protein US6 on the transporter associated with antigen processing.
Dugan GE; Hewitt EW
J Gen Virol; 2009 Sep; 90(Pt 9):2234-8. PubMed ID: 19439551
[TBL] [Abstract][Full Text] [Related]
2. Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6.
Dugan GE; Hewitt EW
J Virol; 2008 Apr; 82(7):3271-82. PubMed ID: 18199642
[TBL] [Abstract][Full Text] [Related]
3. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.
Hengel H; Koopmann JO; Flohr T; Muranyi W; Goulmy E; Hämmerling GJ; Koszinowski UH; Momburg F
Immunity; 1997 May; 6(5):623-32. PubMed ID: 9175840
[TBL] [Abstract][Full Text] [Related]
4. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.
Hewitt EW; Gupta SS; Lehner PJ
EMBO J; 2001 Feb; 20(3):387-96. PubMed ID: 11157746
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses.
Kim Y; Park B; Cho S; Shin J; Cho K; Jun Y; Ahn K
PLoS Pathog; 2008 Aug; 4(8):e1000123. PubMed ID: 18688275
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6.
Kyritsis C; Gorbulev S; Hutschenreiter S; Pawlitschko K; Abele R; Tampé R
J Biol Chem; 2001 Dec; 276(51):48031-9. PubMed ID: 11606590
[TBL] [Abstract][Full Text] [Related]
7. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K
Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839
[TBL] [Abstract][Full Text] [Related]
8. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing.
Halenius A; Momburg F; Reinhard H; Bauer D; Lobigs M; Hengel H
J Biol Chem; 2006 Mar; 281(9):5383-90. PubMed ID: 16356928
[TBL] [Abstract][Full Text] [Related]
9. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses.
Momburg F; Hengel H
Curr Top Microbiol Immunol; 2002; 269():57-74. PubMed ID: 12224516
[TBL] [Abstract][Full Text] [Related]
10. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
Levitt JM; Howell DD; Rodgers JR; Rich RR
Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
[TBL] [Abstract][Full Text] [Related]
11. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
Pande NT; Powers C; Ahn K; Früh K
J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
[TBL] [Abstract][Full Text] [Related]
12. Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatic evaluation.
Doytchinova I; Hemsley S; Flower DR
J Immunol; 2004 Dec; 173(11):6813-9. PubMed ID: 15557175
[TBL] [Abstract][Full Text] [Related]
13. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
[TBL] [Abstract][Full Text] [Related]
14. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.
Lehner PJ; Karttunen JT; Wilkinson GW; Cresswell P
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6904-9. PubMed ID: 9192664
[TBL] [Abstract][Full Text] [Related]
15. Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.
Lorente E; Infantes S; Barnea E; Beer I; Barriga A; García-Medel N; Lasala F; Jiménez M; Admon A; López D
PLoS One; 2013; 8(3):e59118. PubMed ID: 23555621
[TBL] [Abstract][Full Text] [Related]
16. Assembly of tapasin-associated MHC class I in the absence of the transporter associated with antigen processing (TAP).
Paulsson KM; Anderson PO; Chen S; Sjögren HO; Ljunggren HG; Wang P; Li S
Int Immunol; 2001 Jan; 13(1):23-9. PubMed ID: 11133831
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
18. MHC class I molecules compete in the endoplasmic reticulum for access to transporter associated with antigen processing.
Knittler MR; Gülow K; Seelig A; Howard JC
J Immunol; 1998 Dec; 161(11):5967-77. PubMed ID: 9834078
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
[TBL] [Abstract][Full Text] [Related]
20. Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen.
Del Val M; Antón LC; Ramos M; Muñoz-Abad V; Campos-Sánchez E
Curr Opin Immunol; 2020 Jun; 64():9-14. PubMed ID: 31935516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
